Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol oral therapy for severe proliferating infantile hemangiomas (Phase III, single-arm)
2010-019754-41Phase 3Completed
- Sponsor
- InfectoPharm
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of propranolol in Capillary Haemangioma, sponsored by InfectoPharm. Primary endpoint: Therapeutic success at end of therapy (Day 181). Started Jul 2010; status: completed.
02
Drugs
propranolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on 2010-019754-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019754-41.